Shenzhen Hightide Biopharmaceutical, Ltd.
USPTO PatentsView assignee record - 17 granted patents across 9 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Shenzhen ranks #17,186 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 9 technology areas.
- #17,186
- of 49,997 US assignees by volume
- Top 46%
- by Innovation Score (36.7/100)
- 10.2
- avg claims per patent
- +367%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R17186 · Foreign Corporation #17,186 · 17 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 17 grants
- MID-PACK #17,186/49,997
- PHOTO-FINISH Shanghai Hugong…
- CPC-NARROW A61P · 9 areas
- INNOV-THIN 36.7/100
- CLAIMS-PAR 10.2 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +367% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Shanghai Hugong Electric (GROUP) Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Shenzhen’s 36.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Shenzhen
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Shenzhen Hightide… · this assignee
Shenzhen Hightide… · this assignee
37 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Shenzhen's Innovation Score is 36.7/100 (top 46% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Shenzhen?
Each dot is one of Shenzhen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Shenzhen’s own 10.2 claims/patent is ABOVE the 2.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Shenzhen's grants concentrate
Shenzhen Hightide Biopharmaceutical, Ltd. is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2024 (4 grants) versus a trough of 1 in 2016. By volume, Shenzhen sits between Shanghai Hugong Electric (GROUP) Co., Ltd. and Shenzhen Segre Electronic Co., Ltd..
Shenzhen's three-year grant acceleration
Shenzhen Hightide Biopharmaceutical, Ltd. shows 9 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Shenzhen's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Shanghai Hugong E…
Shanghai Hugong Electric (GROUP) Co., Ltd.
17 patents
- Shanghai Lianshan…
Shanghai Lianshang Network Technology Co., Ltd.
17 patents
- Shanghai Putao Te…
Shanghai Putao Technology Co., Ltd.
17 patents
- Shenyang Sinochem…
Shenyang Sinochem Agrochemicals R&D Co., Ltd.
17 patents
- Shenzhen Jamr Tec…
Shenzhen Jamr Technology Co., Ltd.
17 patents
- Shenzhen O-film T…
Shenzhen O-film Tech. Co., Ltd.
17 patents
- Shenzhen Patpet T…
Shenzhen Patpet Technology Co., Ltd.
17 patents
- Shenzhen Segre
Shenzhen Segre Electronic Co., Ltd.
17 patents
- Shenzhen Hightide… ◀
Shenzhen Hightide Biopharmaceutical, Ltd.
17 patents
What this shows Shenzhen holds 17 patents at rank #17,162, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Shenzhen
By rank, the assignees closest to #17,162 in granted patent volume.
- Shanghai Hugong Electric (GROUP) Co., Ltd. #17,158 · 17 patents
- Shanghai Lianshang Network Technology Co., Ltd. #17,159 · 17 patents
- Shanghai Putao Technology Co., Ltd. #17,160 · 17 patents
- Shenyang Sinochem Agrochemicals R&D Co., Ltd. #17,161 · 17 patents
- Shenzhen Jamr Technology Co., Ltd. #17,163 · 17 patents
- Shenzhen O-film Tech. Co., Ltd. #17,164 · 17 patents
- Shenzhen Patpet Technology Co., Ltd. #17,165 · 17 patents
- Shenzhen Segre Electronic Co., Ltd. #17,166 · 17 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Shenzhen's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Shenzhen's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
37 Top 46% higher than 54% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 5.9% |
| 2017 | 1 | 5.9% |
| 2019 | 1 | 5.9% |
| 2020 | 2 | 11.8% |
| 2021 | 3 | 17.6% |
| 2022 | 2 | 11.8% |
| 2023 | 3 | 17.6% |
| 2024 | 4 | 23.5% |
Which technologies does Shenzhen Hightide Biopharmaceutical, Ltd. patent most?
Top 9 of 9 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Shenzhen Hightide Biopharmaceutical, Ltd.'s patent record in context - here's where to go next.
- Shenzhen Hightide Biopharmaceutical, Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #17,186 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Shenzhen Hightide Biopharmaceutical, Ltd. against Shanghai Hugong Electric (GROUP) Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 36.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.